Erosion of the scope of the Orphan Drug Act in the United States

Author： W F.A.  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.15, Iss.6, 2001-12, pp. : 277-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiopharmaceuticals for Drug Development: United States Regulatory Perspective

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 2-6

Bentham Science Publishers

Access to resources Recommend Favorite

EU orphan drug designations

By  

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Orphan drug designation in the EU

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Orphan drug rationing remains a challenge

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 502, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Orphan drug rationing remains a challenge

By  

Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite